ConductScience.org, home

Paper65605

High remission-induction rate in acute myeloid leukaemia.

Gale RP and 1 other. Lancet, 1977. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. High remission-induction rate in acute myeloid leukaemia. Papers, record 65605. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/65605

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High remission-induction rate in acute myeloid leukaemia.
PubMed
Journal
Lancet
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
7.02
iCite
Revised in PubMed
2019-06-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gale RPR P
2Cline MJM J

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytarabineMajor topic
DaunorubicinMajor topic
Leukemia, Myeloid, AcuteMajor topic
ThioguanineMajor topic
Administration, Oral
Adult
Age Factors
Aged
Drug Administration Schedule
Drug Evaluation
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Injections, Intravenous
Male
Middle Aged
Remission, Spontaneous
Time Factors

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
27517413Acute myeloid leukaemia-A review of sixty-seven cases.Ir J Med Sci1979https://conductscience.org/library/papers/27517413PubMed
26965440Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.Leukemia2016https://conductscience.org/library/papers/26965440PubMed
25517921Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia.Braz J Med Biol Res2015https://conductscience.org/library/papers/25517921PubMed
20425452The role of timed sequential chemotherapy in adult acute myelogenous leukemia.Curr Hematol Malig Rep2008https://conductscience.org/library/papers/20425452PubMed
8149141Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.Support Care Cancer1993https://conductscience.org/library/papers/8149141PubMed
8061102A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia.Ann Hematol1994https://conductscience.org/library/papers/8061102PubMed
7347042Remission-induction regimens in acute nonlymphocytic leukemia.West J Med1980https://conductscience.org/library/papers/7347042PubMed
7260406Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients.Blut1981https://conductscience.org/library/papers/7260406PubMed
7139848A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7139848PubMed
7015003[Bone marrow transplantation for relapsed, acute leukaemia (author's transl)].Klin Wochenschr1981https://conductscience.org/library/papers/7015003PubMed
7003128Chemotherapy of the myeloid leukaemias.J R Coll Physicians Lond1980https://conductscience.org/library/papers/7003128PubMed
7000284Advances in the management of adult acute myelogenous leukaemia.Br Med J1980https://conductscience.org/library/papers/7000284PubMed
6954016
Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].
Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6954016PubMed
6931626[Long-term survival of adults with acute leukemia [author's transl)].Blut1980https://conductscience.org/library/papers/6931626PubMed
6931109Acute myelogenous leukaemia with bilateral mammary gland involvement.J Clin Pathol1980https://conductscience.org/library/papers/6931109PubMed
6930301Null results in clinical trials: the need for a decision-theory approach.Br J Cancer1980https://conductscience.org/library/papers/6930301PubMed
6928791The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia.Blut1980https://conductscience.org/library/papers/6928791PubMed
6887757Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination.Klin Wochenschr1983https://conductscience.org/library/papers/6887757PubMed
6803909Short-term treatment for acute myelogenous leukaemia.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6803909PubMed
6781618Long survival in acute myelogenous leukaemia: an international collaborative study.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6781618PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/65605

GET https://conductscience.org/api/papers/v1/65605/cited_by?page=2